Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing office-based methadone versus buprenorphine to improve retention in opioid use disorder treatment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methadone (methadone)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 4 | Status: RECRUITING